These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21593729)

  • 21. Heterogeneous PrPC metabolism in skeletal muscle cells.
    Massimino ML; Ferrari J; Sorgato MC; Bertoli A
    FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
    Ayrolles-Torro A; Imberdis T; Torrent J; Toupet K; Baskakov IV; Poncet-Montange G; Grégoire C; Roquet-Baneres F; Lehmann S; Rognan D; Pugnière M; Verdier JM; Perrier V
    J Neurosci; 2011 Oct; 31(42):14882-92. PubMed ID: 22016521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role for prion protein?
    Barinaga M
    Science; 1997 Nov; 278(5342):1404-5. PubMed ID: 9411764
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple roles for PrP in the prion diseases.
    Estibeiro JP
    Trends Neurosci; 1996 Jul; 19(7):257-8. PubMed ID: 8799966
    [No Abstract]   [Full Text] [Related]  

  • 26. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.
    Hackl S; Becker CFW
    J Pept Sci; 2019 Oct; 25(10):e3216. PubMed ID: 31713950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
    Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
    J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
    Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
    Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia and prion disease: a review.
    Brown DR; Kretzschmar HA
    Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic prion protein induces forebrain neurotoxicity.
    Wang X; Bowers SL; Wang F; Pu XA; Nelson RJ; Ma J
    Biochim Biophys Acta; 2009 Jun; 1792(6):555-63. PubMed ID: 19281844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trafficking, turnover and membrane topology of PrP.
    Harris DA
    Br Med Bull; 2003; 66():71-85. PubMed ID: 14522850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells.
    Roucou X; Giannopoulos PN; Zhang Y; Jodoin J; Goodyer CG; LeBlanc A
    Cell Death Differ; 2005 Jul; 12(7):783-95. PubMed ID: 15846375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Almost a century of prion protein(s): From pathology to physiology, and back to pathology.
    Peggion C; Bertoli A; Sorgato MC
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1148-1155. PubMed ID: 27581199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.